ABGX Abgenix (MM)

FREMONT, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) will present at the 24th Annual JPMorgan Healthcare Conference on Monday, January 9, 2006 at 2:00 p.m. (PT). Bill Ringo, president and chief executive officer of Abgenix, will provide a corporate overview. The presentation will be webcast live and available for replay via the following link: http://www.mapdigital.com/jpmorgan/healthcare06 The webcast will also be available on the Abgenix website: http://www.abgenix.com/ About Abgenix Abgenix is a biopharmaceutical company focused on the discovery, development and manufacturing of human therapeutic antibodies. The company's antibody development platform includes a leading technology and state-of-the-art manufacturing capabilities that enable the rapid generation, selection and production of high affinity, fully human antibody product candidates to a variety of disease targets. Abgenix leverages its leadership position in human antibody technology to build a diversified product portfolio through the establishment of collaborations with multiple pharmaceutical and biotechnology companies. For more information on Abgenix, visit the company's website at http://www.abgenix.com/. DATASOURCE: Abgenix, Inc. CONTACT: Greg Mann, Director of Corporate Communications & Investor Relations of Abgenix, +1-510-284-6566, or +1-510-284-6605 Web site: http://www.abgenix.com/

Copyright